Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches

Maria Teresa Gentile, Gianluca Muto, Giacomo Lus, Karl-Olof Lövblad, Åsa Fex Svenningsen, Luca Colucci-D'Amato*

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

4 Downloads (Pure)

Abstrakt

Multiple sclerosis is a chronic disease of the central nervous system characterized by demyelination and destruction of axons. The most common form of the disease is the relapsing-remitting multiple sclerosis in which episodic attacks with typical neurological symptoms are followed by episodes of partial or complete recovery. One of the underestimated factors that contribute to the pathogenesis of multiple sclerosis is excessive angiogenesis. Here, we review the role of angiogenesis in the onset and in the development of the disease, the molecular mechanisms underlying angiogenesis, the current therapeutic approaches, and the potential therapeutic strategies with a look at natural compounds as multi-target drugs with both neuroprotective and anti-angiogenic properties
OriginalsprogEngelsk
Artikelnummer4643
TidsskriftJournal of Clinical Medicine
Vol/bind11
Udgave nummer16
Antal sider11
ISSN2077-0383
DOI
StatusUdgivet - 9. aug. 2022

Fingeraftryk

Dyk ned i forskningsemnerne om 'Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches'. Sammen danner de et unikt fingeraftryk.

Citationsformater